Hesperidin-mediated selenium nanoparticles protect against diabetic cisplatin-induced testicular injury via modulation of Nrf2/Keap1, TLR4/NF-κB/MAPK, and PERK/CHOP Signaling
Publication date: February 2027 Source: Tissue and Cell, Volume 104, Part 3 Author(s): Ibrahim Jafri, Eman Fayad, Khalaf N. Alsiaam, Hajer A. Alfarteesh, Maha Alsunbul, Mohamed A. Ali, Sara Youssif Ibrahim, Nievin Ahmed Mahran, Haitham lbrahim El-Mekkawy, Khaled M. Alam-ElDein, Mohamed H.A. Gadelmawla
Hesperidin-mediated selenium nanoparticles protect against diabetic cisplatin-induced testicular injury via modulation of Nrf2/Keap1, TLR4/NF-κB/MAPK, and PERK/CHOP Signaling. // Tissue and Cell. – URL: https://www.sciencedirect.com/science/article/pii/S0040816626007652?dgcid=rss_sd_all
Hesperidin-mediated selenium nanoparticles protect against diabetic cisplatin-induced testicular injury via modulation of Nrf2/Keap1, TLR4/NF-κB/MAPK, and PERK/CHOP Signaling. Tissue and Cell. https://www.sciencedirect.com/science/article/pii/S0040816626007652?dgcid=rss_sd_all
“Hesperidin-mediated selenium nanoparticles protect against diabetic cisplatin-induced testicular injury via modulation of Nrf2/Keap1, TLR4/NF-κB/MAPK, and PERK/CHOP Signaling.” Tissue and Cell.
@article{article91024,
title = {Hesperidin-mediated selenium nanoparticles protect against diabetic cisplatin-induced testicular injury via modulation of Nrf2/Keap1, TLR4/NF-κB/MAPK, and PERK/CHOP Signaling},
journal = {Tissue and Cell},
url = {https://www.sciencedirect.com/science/article/pii/S0040816626007652?dgcid=rss_sd_all}
}
Publication date: January 2027 Source: Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, Volume 1872, Issue 1 Author(s): Carlos Paya, João Pereira, Paulo Cartaxana, Rita Pais, Maite Mascaró, Tânia Melo, Pedro...